Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson (NYSE: JNJ): First Quarter 2010 Earnings Preview
iStockAnalyst
Friday, April 9, 2010 - 11:30am
tags:
earnings, JNJ
Sanofi opens R&D center in China
Fierce Biotech
Friday, April 9, 2010 - 11:28am
tags:
R&D, China, Sanofi
Lawyer for female Novartis workers says they are cheated but company denies claim in NYC trial
SF Examiner, CA
Friday, April 9, 2010 - 11:28am
tags:
Novartis, discrimination
Celgene says stem cell therapy met safety goal
Yahoo/AP
Friday, April 9, 2010 - 11:27am
tags:
Celgene, stem cells, Crohn's Disease
Boston Scientific Mulls Sale of Two Units
TheStreet.com
Friday, April 9, 2010 - 11:25am
tags:
M&A, Boston Scientific, Abbott Laboratories, JNJ
Cell Therapeutics Closer to the Brink
TheStreet.com
Friday, April 9, 2010 - 7:56am
tags:
Cell Therapeutics, pixantrone
Study: St. Jude, Medtronic could benefit from Boston Sci woes
Fierce Medical Devices
Friday, April 9, 2010 - 7:55am
tags:
Boston Scientific, St. Jude Medical, Medtronic, defibrillators
Merck KGaA’s $6 Billion Millipore Deal ’Worth Every Euro’
Bloomberg
Friday, April 9, 2010 - 7:53am
tags:
Merck KGaA, M&A, Millipore
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Friday, April 9, 2010 - 7:52am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis, PML
King Advances Pain Candidate
Yahoo/Zacks.com
Friday, April 9, 2010 - 7:51am
tags:
King, Durect Corporation, painkillers, Eladur, Pain Therapeutics
Novartis aware of gender discrimination for years, lawyer says
NY Post, NY
Thursday, April 8, 2010 - 5:53pm
tags:
discrimination, Novartis, lawsuits
Good News for MDRNA
Yahoo/Zacks.com
Thursday, April 8, 2010 - 5:51pm
tags:
MDRNA, Cequent Pharmaceuticals, M&A
FDA recruits consumer reps for advisory panels
Fierce Pharma
Thursday, April 8, 2010 - 2:28pm
tags:
FDA, advisory panels
Prospecting for Stocks: Forest Laboratories
Motley Fool
Thursday, April 8, 2010 - 2:27pm
tags:
Forest Labs
Keryx, AEterna Zentaris announce trial start for cancer drug perifosine
Yahoo/AP
Thursday, April 8, 2010 - 2:25pm
tags:
Keryx, Aeterna Zentaris, clinical trials, perifosine, colorectal cancer
After Google-Apple, Can Biogen Directors Sit on Genzyme Board?
WSJ Online
Thursday, April 8, 2010 - 10:54am
tags:
Biogen Idec, Genzyme
PhRMA taps Astra exec for transition help
Fierce Pharma
Thursday, April 8, 2010 - 10:52am
tags:
PhRMA, AstraZeneca
Forest Labs leads drug stocks south
Marketwatch
Thursday, April 8, 2010 - 10:49am
tags:
drug stocks, Forest Labs
COPD Drug Class Gasping for Breath
WSJ Online
Thursday, April 8, 2010 - 10:47am
tags:
COPD, Forest Labs, Nycomed, Otsuka, Glenmark, Orexo
Louisiana to get $20 million in Eli Lilly settlement over marketing of anti-psychotic Zyprexa
Yahoo/AP
Thursday, April 8, 2010 - 9:51am
tags:
Zyprexa, settlements, Eli Lilly, Louisiana

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.